Skandinaviska Enskilda Banken (SEB)
FLXN

Skandinaviska Enskilda Banken (SEB)’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,800
Closed -$116K – 1141
2020
Q2 		$116K Buy
+8,800
New +$91.3K ﹤0.01% 953

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s FLXN Position: Q3 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2020, closing a stake of 8,800 shares — an estimated $116K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in FLXN in Q2 2020 and held it in 1 quarter. The position peaked at $116K in Q2 2020. 135 funds tracked by Wall St. Rank hold FLXN as of Q3 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Flexion Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 8,800 Flexion Therapeutics, Inc. shares in Q3 2020, an estimated $116K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Flexion Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Flexion Therapeutics, Inc. position peaked at $116K in Q2 2020.
  • 135 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2020, filed 12 Nov 2020.